Shapely Tirzepatide Review: Medication Prices, Membership & Care

Shapely separates the price of medical membership from medication. Its compounded tirzepatide page lists $249/month for low-to-mid doses and $299/month for high doses, while the $166/month headline belongs to a $498 three-month starter package. Membership is required and costs extra; a lower displayed monthly equivalent is not the full amount due.^3,4

This is a video-based weight-management service with cash-pay compounded medication and a separate branded-prescription pathway. Insurance participation can help eligible patients with visits or certain prescriptions, but it does not guarantee a covered drug, a particular copay or access in every state.

Compare the medication charge with the membership

The named tirzepatide pricing table also lists three-month refill packages at $597 for low-to-mid doses and $837 for high doses. These are published package totals, not the monthly payment amounts. Shipping, syringes and alcohol pads are described as included in the medication offer. The clinician selects the prescription; the pricing categories are not instructions to choose a dose.³

For self-pay care, the membership is advertised at $49 for the first month and $99 monthly thereafter. Medication is excluded. Labs are also excluded, with a $75 Labcorp option for uninsured patients. The site says recent labs are strongly recommended rather than universally required before most weight-loss prescriptions.⁴

Patients using insurance can still owe membership fees, visit copays, deductibles or coinsurance, and medication cost-sharing. The site describes insurance-assisted access to branded drugs including Zepbound and Mounjaro, while compounded medication is cash-pay. Confirm coverage for the actual diagnosis, prescription and plan rather than treating “insurance accepted” as a guarantee.⁴

Compounded and branded routes remain different

The named product page explicitly describes compounded injectable tirzepatide. The company says it works with 503A and 503B pharmacies but does not identify the actual dispensing facility in these product disclosures. That is a claimed partner-network description, not independent verification of the pharmacy assigned to a patient. Our guide to compounded tirzepatide’s legal status explains why a compounded preparation is different from an FDA-approved finished product.³

Shapely's branded-prescription route is a separate clinical and payment decision. It describes assistance with prior authorization or eligible manufacturer cash programs, not a promise that every applicant can obtain a covered branded medicine. Compare the total care and medication expense for the route actually prescribed.⁴

Care access, eligibility and who treats you

The public FAQ currently lists adults in California, Florida, New York and Texas. An individual team member's multistate credentials or an announced expansion is not proof that the service currently accepts patients nationwide. The plan advertises monthly provider video visits and app/chat support; the insurance plan specifically lists monthly dietitian visits and a conditional smart scale.⁴

The About page identifies founder Justin Zaghi, medical director Ana Lisa Carr, and a broader team including physician assistants, nurse practitioners and dietitians. These are company-published biographies, not confirmation of the clinician assigned to each patient or an independent credential audit. The Terms of Use identify Zaghi Medical, Inc. doing business as Shapely and preserve the clinician's discretion to decline a prescription or recommend other care.^6,7

Clinical monitoring is separate from headline outcomes. Ask who reviews adverse effects and refill questions, and which visits are included in the chosen payment route. Discuss labeled risks with the treating clinician; our guides cover Zepbound side effects, gallbladder risks and the thyroid cancer warning.

Renewal and refunds

The February 18, 2026 recurring-payment consent authorizes monthly automatic renewal. Cancel before the current subscription period ends; the account closes at the end of that paid month. It provides email and telephone methods to stop recurring payment, with already-incurred charges still owed. No partial-month refund is promised, and erroneous charges are reviewed case by case.⁵

That consent concerns monthly subscriptions and should not be treated as a complete return policy for a three-month medication package. Confirm the package's payment, renewal, clinical-decline and cancellation treatment before purchase. Use the stated cancellation channel and keep confirmation.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Who should compare Shapely

Shapely is worth examining for someone in its listed service area who wants video-based care and help navigating insurance or cash-pay medication. Its most useful price comparison adds the membership and any labs to the actual medication purchase. The lowest package equivalent alone understates that commitment.

The Signos review offers another care model to assess. Our best tirzepatide providers comparison can help compare published costs, but each provider's eligibility, prescription and financial terms remain separate.